Literature DB >> 2887790

Pharmacokinetic case for giving 6-mercaptopurine maintenance doses at night.

A M Langevin, G Koren, S J Soldin, M Greenberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2887790     DOI: 10.1016/s0140-6736(87)91808-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Review: therapeutic drug monitoring in pediatrics.

Authors:  Offie Porat Soldin; Steven J Soldin
Journal:  Ther Drug Monit       Date:  2002-02       Impact factor: 3.681

2.  Pharmacokinetics of 4' epi-adriamycin after morning and afternoon intravenous administration.

Authors:  S Eksborg; U Stendahl; K Antila
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

3.  Variability of 6-mercaptopurine pharmacokinetics during oral maintenance therapy of children with acute leukemia.

Authors:  P Lafolie; O Björk; S Hayder; L Ahström; C Peterson
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

Review 4.  Comparative tolerability of treatments for inflammatory bowel disease.

Authors:  R B Stein; S B Hanauer
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

5.  Intraindividual variation in 6-mercaptopurine pharmacokinetics during oral maintenance therapy of children with acute lymphoblastic leukaemia.

Authors:  P Lafolie; S Hayder; O Björk; C Peterson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 6.  Pharmacokinetic optimisation of anticancer therapy.

Authors:  J Liliemark; C Peterson
Journal:  Clin Pharmacokinet       Date:  1991-09       Impact factor: 6.447

7.  Diurnal variation of methotrexate disposition in children with acute leukaemia.

Authors:  G Ferrazzini; H Sohl; I Robieux; D Johnson; E Giesbrecht; G Koren
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.